We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
26
ConocoPhillips
COP
$147B
$21.5M 1.4%
182,029
+3,733
+2% +$454K
STZ icon
27
Constellation Brands
STZ
$22.2B
$21.3M 1.38%
91,867
+6,488
+8% +$1.55M
FDS icon
28
Factset
FDS
$9.36B
$21.1M 1.37%
52,551
+642
+1% +$273K
IRM icon
29
Iron Mountain
IRM
$36.4B
$20.5M 1.34%
412,009
+7,763
+2% +$392K
BAH icon
30
Booz Allen Hamilton
BAH
$8.39B
$20.1M 1.31%
192,263
+19,107
+11% +$1.99M
ELV icon
31
Elevance Health
ELV
$81.5B
$19.8M 1.29%
38,688
+403
+1% +$205K
CI icon
32
Cigna
CI
$73.8B
$19.5M 1.27%
58,850
+1,210
+2% +$383K
RJF icon
33
Raymond James Financial
RJF
$33.8B
$19.5M 1.27%
182,406
+4,020
+2% +$451K
GS icon
34
Goldman Sachs
GS
$300B
$19.1M 1.24%
55,563
+50,225
+941% +$17.5M
ALB icon
35
Albemarle
ALB
$13.9B
$18.6M 1.21%
85,610
+2,139
+3% +$570K
HWM icon
36
Howmet Aerospace
HWM
$113B
$16M 1.04%
407,203
+22,381
+6% +$816K
CB icon
37
Chubb
CB
$135B
$16M 1.04%
72,381
+2,325
+3% +$484K
ANET icon
38
Arista Networks
ANET
$227B
$15.9M 1.03%
524,272
+13,912
+3% +$428K
ACGL icon
39
Arch Capital
ACGL
$34.3B
$15.5M 1.01%
246,343
+5,660
+2% +$316K
FCNCA icon
40
First Citizens BancShares
FCNCA
$24.9B
$15.4M 1%
+20,251
New +$16.3M
CF icon
41
CF Industries
CF
$19.2B
$15.2M 0.99%
178,943
+2,963
+2% +$301K
VICI icon
42
VICI Properties
VICI
$29B
$14.5M 0.94%
446,411
-35,454
-7% -$1.14M
ADI icon
43
Analog Devices
ADI
$179B
$13.1M 0.85%
79,842
+1,458
+2% +$228K
PAYX icon
44
Paychex
PAYX
$41.6B
$12.5M 0.82%
108,473
+1,608
+2% +$188K
FE icon
45
FirstEnergy
FE
$28B
$12.3M 0.8%
294,263
+3,918
+1% +$153K
K
46
DELISTED
Kellanova
K
$12.1M 0.79%
180,493
+33,259
+23% +$2.26M
AXP icon
47
American Express
AXP
$227B
$12M 0.78%
81,316
-16,936
-17% -$2.51M
JBL icon
48
Jabil
JBL
$33B
$11.9M 0.77%
173,953
+4,008
+2% +$265K
LOW icon
49
Lowe's Companies
LOW
$117B
$11.2M 0.73%
56,459
+7,004
+14% +$1.4M
KBR icon
50
KBR
KBR
$4.64B
$10.1M 0.66%
191,023
+4,270
+2% +$213K

Similar funds

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.